Return to Article Details
EVALUATION OF CHANGES IN INTERLEUKIN-4 LEVELS WHEN USING THE IMMUNOMODULATOR GEPON IN THE TREATMENT OF PATIENTS WITH CUTANEOUS LEISHMANIASIS
Download
Download PDF